These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34333393)

  • 1. Synthesis and biological evaluation of novel 1,4-benzodiazepin-3-one derivatives as potential antitumor agents against prostate cancer.
    Vézina-Dawod S; Perreault M; Guay LD; Gerber N; Gobeil S; Biron E
    Bioorg Med Chem; 2021 Sep; 45():116314. PubMed ID: 34333393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis and Biological Evaluation of 1-methyl-1H-pyrazole-5-Carboxamide Derivatives as Novel Anti-Prostate Cancer Agents.
    Chen X; Xu C; Li Y; Duan X; Zhao G
    Anticancer Agents Med Chem; 2021; 21(17):2368-2378. PubMed ID: 33530916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anticancer evaluation of 6-azacyclonol-2,4,6-trimethylpyridin-3-ol derivatives: M3 muscarinic acetylcholine receptor-mediated anticancer activity of a cyclohexyl derivative in androgen-refractory prostate cancer.
    Karmacharya U; Chaudhary P; Lim D; Dahal S; Awasthi BP; Park HD; Kim JA; Jeong BS
    Bioorg Chem; 2021 May; 110():104805. PubMed ID: 33725508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation and X-ray analysis of bicalutamide sulfoxide analogues for the potential treatment of prostate cancer.
    Kandil SB; Kariuki BM; McGuigan C; Westwell AD
    Bioorg Med Chem Lett; 2021 Mar; 36():127817. PubMed ID: 33513386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.
    Chen H; Xu F; Liang X; Xu BB; Yang ZL; He XL; Huang BY; Yuan M
    Bioorg Med Chem Lett; 2015 Jan; 25(2):285-7. PubMed ID: 25488843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of new 1,3,4-benzotriazepin-5-one derivatives and their biological evaluation as antitumor agents.
    Taher AT; Mohammed LW
    Arch Pharm Res; 2013 Jun; 36(6):684-93. PubMed ID: 23504247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of naphthalene-based thiosemicarbazone derivatives as new anticancer agents against LNCaP prostate cancer cells.
    Altintop MD; Sever B; Özdemir A; Kuş G; Oztopcu-Vatan P; Kabadere S; Kaplancikli ZA
    J Enzyme Inhib Med Chem; 2016; 31(3):410-6. PubMed ID: 25826149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
    Morales P; Vara D; Goméz-Cañas M; Zúñiga MC; Olea-Azar C; Goya P; Fernández-Ruiz J; Díaz-Laviada I; Jagerovic N
    Eur J Med Chem; 2013; 70():111-9. PubMed ID: 24141201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF
    Pertusati F; Ferla S; Bassetto M; Brancale A; Khandil S; Westwell AD; McGuigan C
    Eur J Med Chem; 2019 Oct; 180():1-14. PubMed ID: 31288149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors.
    Li K; Li Y; Zhou D; Fan Y; Guo H; Ma T; Wen J; Liu D; Zhao L
    Bioorg Med Chem; 2016 Apr; 24(8):1889-97. PubMed ID: 26979485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 3,4-diazabenzotropone compounds (2,3-benzodiazepin-5-ones): synthesis, unique reactivity, and biological evaluation.
    Matsuya Y; Katayanagi H; Ohdaira T; Wei ZL; Kondo T; Nemoto H
    Org Lett; 2009 Mar; 11(6):1361-4. PubMed ID: 19231851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of chalcone-polyamine conjugates as novel vectorized agents in colorectal and prostate cancer chemotherapy.
    Rioux B; Pinon A; Gamond A; Martin F; Laurent A; Champavier Y; Barette C; Liagre B; Fagnère C; Sol V; Pouget C
    Eur J Med Chem; 2021 Oct; 222():113586. PubMed ID: 34116328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel androgen receptor degrading agents to treat advanced prostate cancer.
    Wu H; Ren J; Zhao L; Li Z; Ye W; Yang Y; Wang J; Bian J
    Eur J Med Chem; 2021 May; 217():113376. PubMed ID: 33756125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico selection and cell-based characterization of selective and bioactive compounds for androgen-dependent prostate cancer cell.
    Cruz EC; Carecho AR; Saidel ME; Montanari CA; Leitão A
    Bioorg Med Chem Lett; 2017 Feb; 27(3):546-550. PubMed ID: 28011219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-generation testosterone-platinum(II) hybrids for site-specific treatment of androgen receptor positive prostate cancer: Design, synthesis and antiproliferative activity.
    Ouellette V; Côté MF; Gaudreault RC; Tajmir-Riahi HA; Bérubé G
    Eur J Med Chem; 2019 Oct; 179():660-666. PubMed ID: 31279298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual screening and biological evaluation of PPARγ antagonists as potential anti-prostate cancer agents.
    Almahmoud S; Elix CC; Jones JO; Hopkins CR; Vennerstrom JL; Zhong HA
    Bioorg Med Chem; 2021 Sep; 46():116368. PubMed ID: 34433102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 17-cyanopyridine derivatives of pregnenolone as potential anti-prostate cancer agents.
    Sun Y; Gao P; Zhu L; Li Z; Zhao R; Li C; Shan L
    Steroids; 2021 Jul; 171():108841. PubMed ID: 33901535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel galeterone derivatives and evaluation of their in vitro activity against prostate cancer cell lines.
    Jorda R; Řezníčková E; Kiełczewska U; Maj J; Morzycki JW; Siergiejczyk L; Bazgier V; Berka K; Rárová L; Wojtkielewicz A
    Eur J Med Chem; 2019 Oct; 179():483-492. PubMed ID: 31271960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
    Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
    J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety.
    Chen H; Zhang J; Hu P; Qian Y; Li J; Shen J
    Bioorg Med Chem; 2019 Oct; 27(20):115081. PubMed ID: 31493989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.